Enhancing Patient Flexibility of Subcutaneous Immunoglobulin G Dosing: Pharmacokinetic Outcomes of Various Maintenance and Loading Regimens in the Treatment of Primary Immunodefici...

por Sidhu, Jagdev, Rojavin, Mikhail, Pfister, Marc, Edelman, Jonathan
Publicado 2014

Quantitative Evidence of Wear-Off Effect at the End of the Intravenous IgG (IVIG) Dosing Cycle in Primary Immunodeficiency

por Rojavin, Mikhail A., Hubsch, Alphonse, Lawo, John-Philip
Publicado 2016

Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies

por Mallick, Rajiv, Jolles, Stephen, Kanegane, Hirokazu, Agbor-Tarh, Dominique, Rojavin, Mikhail
Publicado 2018

Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert(®) (C1-INH) Registry

por Bygum, Anette, Martinez-Saguer, Inmaculada, Bas, Murat, Rosch, Jeffrey, Edelman, Jonathan, Rojavin, Mikhail, Williams-Herman, Debora
Publicado 2016

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

por Hagan, John B., Fasano, Mary B., Spector, Sheldon, Wasserman, Richard L., Melamed, Isaac, Rojavin, Mikhail A., Zenker, Othmar, Orange, Jordan S.
Publicado 2010

Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials

por Jolles, Stephen, Rojavin, Mikhail A., Lawo, John-Philip, Nelson, Robert, Wasserman, Richard L., Borte, Michael, Tortorici, Michael A., Imai, Kohsuke, Kanegane, Hirokazu
Publicado 2018

Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency

por Rojavin, Mikhail A., Chapdelaine, Hugo, Tortorici, Michael A., Praus, Michaela, Baheti, Gautam, Zhang, Ying, Hofmann, Jutta, Labrosse, Roxane, Dicaire, Renée, Haddad, Elie
Publicado 2019

Clinical Experience With an L-Proline–Stabilized 10 % Intravenous Immunoglobulin (Privigen®): Real-Life Effectiveness and Tolerability

por Dorsey, Morna J., Ho, Viet, Mabudian, Mohsen, Soler-Palacín, Pere, Domínguez-Pinilla, Nerea, Rishi, Radha, Rishi, Rahul, Wong, Duane, Rojavin, Mikhail, Hubsch, Alphonse, Berger, Melvin
Publicado 2014

Safety and Tolerability of Manual Push Administration of Subcutaneous IgPro20 at High Infusion Rates in Patients with Primary Immunodeficiency: Findings from the Manual Push Admini...

por Cowan, Juthaporn, Bonagura, Vincent R., Lugar, Patricia L., Maglione, Paul J., Patel, Niraj C., Vinh, Donald C., Hofmann, Jutta H., Praus, Michaela, Rojavin, Mikhail A.
Publicado 2020

Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases

por Kanegane, Hirokazu, Imai, Kohsuke, Yamada, Masafumi, Takada, Hidetoshi, Ariga, Tadashi, Bexon, Martin, Rojavin, Mikhail, Hu, Wilson, Kobayashi, Midori, Lawo, John-Philip, Nonoyama, Shigeaki, Hara, Toshiro, Miyawaki, Toshio
Publicado 2014

Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the...

por Anderson, John T., Bonagura, Vincent R., Cowan, Juthaporn, Hsu, Connie, Mustafa, S. Shahzad, Patel, Niraj C., Routes, John M., Sriaroon, Panida, Vinh, Donald C., Hofmann, Jutta H., Praus, Michaela, Rojavin, Mikhail A.
Publicado 2021

Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema

por Craig, Timothy, Shapiro, Ralph, Vegh, Arthur, Baker, James W., Bernstein, Jonathan A., Busse, Paula, Magerl, Markus, Martinez-Saguer, Inmaculada, Riedl, Marc A., Lumry, William, Williams-Herman, Debora, Edelman, Jonathan, Feuersenger, Henrike, Machnig, Thomas, Rojavin, Mikhail
Publicado 2017